60 DEGREES PHARMACEUTICALS I
COM NEW · CUSIP 83006G401
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q1 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2025 | 7 |
| Q2 2025 | 6 |
| Q3 2025 | 7 |
| Q4 2025 | 7 |
| Q1 2026 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2025 | 3 | 2 |
| Q3 2025 | 5 | 1 |
| Q4 2025 | 4 | 2 |
| Q1 2026 | 0 | 7 |
Biggest buyers
| None |
Biggest sellers
| JANE STREET GROUP, LLC | Sold out | -22.1k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -12.4k |
| Tower Research Capital LLC (TRC) | Sold out | -6.7k |
| BARCLAYS PLC | Sold out | -1.5k |
| UBS Group AG | Sold out | -1.5k |
| OSAIC HOLDINGS, INC. | Sold out | -100 |
| BANK OF AMERICA CORP /DE/ | Sold out | -31 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| CVI Investments, Inc. 13G · passive investor no change · filed 2025-11-07 | 9.9% |
Fell to 5% or below in the last year: Ayrton Capital LLC (4.1%, 2025-11-13)
Holders, Q1 2026
| Manager | Shares | Change |
|---|